Elucidating the specific pharmacological system of action (MOA) of naturally happening compounds is often hard. Although Tarselli et al. (60) designed the 1st de novo synthetic pathway to conolidine and showcased that this naturally developing compound efficiently suppresses responses to the two chemically induced and inflammation-derived pain, the pharmacologic https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers